IBDIQ glossary

A shared understanding of vocabulary is crucial for effective communication. Think of this glossary as your quick-reference guide to help you navigate key terms related to IBD.

References: 1. Aminosalicylates fact sheet. Crohn’s & Colitis Foundation. Updated October 2018. Accessed July 23, 2025. https://www.crohnscolitisfoundation.org/sites/default/files/legacy/assets/pdfs/aminosalicylates.pdf 2. Haq MI, Ahmed S, Pasha W, Zaidi SAA. Mesalazine-induced cardiotoxicity. J Rare Disord Diagn Ther. 2019;4:1-5. 3. Intestinal obstruction repair. MedlinePlus. Updated March 31, 2024. Accessed July 23, 2025. https://medlineplus.gov/ency/article/002927.htm 4. FA Davis. Taber’s Online. Taber’s website. https://www.tabers.com/tabersonline. Accessed July 23, 2025. 5. Park SC, Jeen YT. Anti-integrin therapy for inflammatory bowel disease. World J Gastroenterol. 2018. 7;24(17): 1868-1880. 6. Antineutrophil Cytoplasmic Antibodies (ANCA) test. MedlinePlus. Updated March 17, 2023. Accessed July 23, 2025. https://medlineplus.gov/lab-tests/antineutrophil-cytoplasmic-antibodies-anca-test 7. Elsevier. Dorland’s Medical Dictionary Online. Dorland’s online website. https://www.dorlandsonline.com/dorland/home. Accessed July 23, 2025. 8. US Food and Drug Administration. Overview of biosimilar products. Accessed July 23, 2025. https://www.fda.gov/files/drugs/published/Biosimilars_Overview.pdf 9. C. diff infections. MedlinePlus. Updated December 13, 2023. Accessed July 23, 2025. https://medlineplus.gov/cdiffinfections.html 10. Janus kinase inhibitors (JAK inhibitors) fact sheet. Crohn’s & Colitis Foundation. Updated October 2018. Accessed July 23, 2025. https://www.crohnscolitisfoundation.org/sites/default/files/legacy/assets/pdfs/jak-inhibitors.pdf 11. Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113:481–517. 12. Kitsou K, Kokkotis G, Rivera-Nieves J, Bamias G. Targeting the sphingosine-1-phosphate pathway: new opportunities in inflammatory bowel disease management. Drugs. 2024;84(10):1179-1197. 13. Lim SZ, Chua EW. Revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring. Front Pharmacol. 2018;9:1107.